National Stroke Foundation


The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Approval Status:

Approved September 1997

Specific Treatments:

anticonvulsant and trigeminal neuralgia

General Information

Carbatrol by Elan Corp. has been approved as a treatment for epileptic seizures and trigeminal neuralgia. Carbatrol is recommended for use twice daily as an extended release drug.